MyFinsight
Home
Blog
About
Marketable securities
$221,840K
(43.40%↑ Y/Y)
Cash and cash
equivalents
$14,711K
(-29.22%↓ Y/Y)
Prepaid expenses and
other current assets
$6,029K
(344.94%↑ Y/Y)
Total current assets
$242,580K
(37.18%↑ Y/Y)
Operating lease
right-of-use assets
$6,494K
(29.70%↑ Y/Y)
Property and equipment,
net
$929K
(8.53%↑ Y/Y)
Other long-term
assets
$364K
(95.70%↑ Y/Y)
Total assets
$250,367K
(36.90%↑ Y/Y)
Total liabilities and
stockholders' equity
$250,367K
(36.90%↑ Y/Y)
Total stockholders'
equity
$239,660K
(39.83%↑ Y/Y)
Total liabilities
$10,707K
(-6.88%↓ Y/Y)
Accumulated deficit
-$206,990K
(-38.52%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$573K
(-489.80%↓ Y/Y)
Additional
paid-in-capital
$447,185K
(39.46%↑ Y/Y)
Total current
liabilities
$6,526K
(-9.54%↓ Y/Y)
Operating lease
liabilities, net of current...
$4,181K
(-2.40%↓ Y/Y)
Common stock-Common
Class A
$33K
(73.68%↑ Y/Y)
Common stock-Common
Class B
$5K
(-28.57%↓ Y/Y)
Accrued expenses
$3,628K
(-3.18%↓ Y/Y)
Current portion of
operating lease...
$2,393K
(63.23%↑ Y/Y)
Accounts payable
$505K
(-74.76%↓ Y/Y)
Back
Back
Balance Sheet
Contineum Therapeutics, Inc. (CTNM)
Contineum Therapeutics, Inc. (CTNM)
source: myfinsight.com